Open AccessTHE EFFICACY OF THE COSTS ON SEVERE RESPIRATORY SYNCYTIAL INFECTION PREVENTION WITH PALIVIZUMAB IN PRETERM INFANTS
Author(s) -
А. В. Рудакова,
И. В. Бабаченко,
V. B. Rovnyi,
A. N. Uskov,
Yu. V. Lobzin
Publication year - 2012
Publication title -
вопросы современной педиатрии
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.12
H-Index - 5
eISSN - 1682-5535
pISSN - 1682-5527
DOI - 10.15690/vsp.v11i4.374
Subject(s) - palivizumab , medicine , pediatrics , indirect costs , gestation , randomized controlled trial , population , etiology , intensive care medicine , respiratory system , environmental health , pregnancy , accounting , biology , business , genetics
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom